Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Deschler-Baier

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Geriatric Oncology|May 5, 2026
Response to Editorial, "Comment on 'Effect of geriatric co-management on independence, quality of life, and severe toxicity in vulnerable older patients with cancer: Results of a randomized clinical trial'"Gabriele Ihorst, Barbara Deschler-Baier
Innere Medizin (Heidelberg, Germany)|September 5, 2025
[Frailty in oncogeriatrics]Nina Rosa Neuendorff, Rainer Wirth, Barbara Deschler-Baier
Journal of Geriatric Oncology|November 18, 2025
More than age: Impact of comorbidity and polypharmacy on immune-related adverse events, treatment discontinuation, and toxicity management in older patients receiving immune checkpoint inhibitorsAnja Gesierich, Eran Demeter, Bastian Schilling, et al.
Journal of Geriatric Oncology|January 13, 2025
Increasing the evidence for comprehensive geriatric assessment - Outlook on another work in progressMiriam Hüttmeyer, Kathrin Tatschner, Elisabeth Jentschke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 21, 2015
An oral care self-management support protocol (OrCaSS) to reduce oral mucositis in hospitalized patients with acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation: a randomized controlled pilot studyLynn Leppla, Sabina De Geest, Katharina Fierz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 25, 2024
Clinical Activity of Selpercatinib in RET-mutant PheochromocytomaBarbara Deschler-Baier, Bhavana Konda, Erminia Massarelli, et al.
Deutsche Medizinische Wochenschrift (1946)|January 31, 2019
[Management of adverse events in immune oncology - Practical aspects of immune-related adverse events during immune oncological treatment]Niels Reinmuth, Michael Bitzer, Barbara Deschler-Baier, et al.
Clinical Nuclear Medicine|January 27, 2022
Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed EndoradiotherapyNatalie Hasenauer, Takahiro Higuchi, Barbara Deschler-Baier, et al.
Archives of Gynecology and Obstetrics|April 4, 2026
Comparative validation of a cost-effective in-house 3D-printed LLETZ simulator versus a commercial training modelAnne Cathrine Scherer-Quenzer, Katharina Reinhart, Joachim Diessner, et al.
Cancers|January 11, 2024
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001Filippo De Braud, Barbara Deschler-Baier, John C Morris, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Geriatric Oncology|May 5, 2026
Response to Editorial, "Comment on 'Effect of geriatric co-management on independence, quality of life, and severe toxicity in vulnerable older patients with cancer: Results of a randomized clinical trial'"Gabriele Ihorst, Barbara Deschler-Baier
Innere Medizin (Heidelberg, Germany)|September 5, 2025
[Frailty in oncogeriatrics]Nina Rosa Neuendorff, Rainer Wirth, Barbara Deschler-Baier
Journal of Geriatric Oncology|November 18, 2025
More than age: Impact of comorbidity and polypharmacy on immune-related adverse events, treatment discontinuation, and toxicity management in older patients receiving immune checkpoint inhibitorsAnja Gesierich, Eran Demeter, Bastian Schilling, et al.
Journal of Geriatric Oncology|January 13, 2025
Increasing the evidence for comprehensive geriatric assessment - Outlook on another work in progressMiriam Hüttmeyer, Kathrin Tatschner, Elisabeth Jentschke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 21, 2015
An oral care self-management support protocol (OrCaSS) to reduce oral mucositis in hospitalized patients with acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation: a randomized controlled pilot studyLynn Leppla, Sabina De Geest, Katharina Fierz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 25, 2024
Clinical Activity of Selpercatinib in RET-mutant PheochromocytomaBarbara Deschler-Baier, Bhavana Konda, Erminia Massarelli, et al.
Deutsche Medizinische Wochenschrift (1946)|January 31, 2019
[Management of adverse events in immune oncology - Practical aspects of immune-related adverse events during immune oncological treatment]Niels Reinmuth, Michael Bitzer, Barbara Deschler-Baier, et al.
Clinical Nuclear Medicine|January 27, 2022
Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed EndoradiotherapyNatalie Hasenauer, Takahiro Higuchi, Barbara Deschler-Baier, et al.
Archives of Gynecology and Obstetrics|April 4, 2026
Comparative validation of a cost-effective in-house 3D-printed LLETZ simulator versus a commercial training modelAnne Cathrine Scherer-Quenzer, Katharina Reinhart, Joachim Diessner, et al.
Cancers|January 11, 2024
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001Filippo De Braud, Barbara Deschler-Baier, John C Morris, et al.
Pageof 2